Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps - Poll - MDSpire

Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps

  • By

  • Bo Wei

  • Weigang Gan

  • Jiaxin Li

  • Feng Wang

  • Jun Wang

  • Binbin Wang

  • Jiaoyu He

  • Feng Liu

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps

  • by Bo Wei, Weigang Gan, Jiaxin Li, Feng Wang, Jun Wang, Binbin Wang, Jiaoyu He, Feng Liu

  • June 15, 2026

Related Content

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

CRS Trial Reveals Surgery Divide

MACRO qualitative study explores why patients differ in attitudes toward endoscopic sinus surgery.

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness